**Meet the editor**

Dr. Kumar has more than 13 years of research experience in the field of bacterial sepsis along with other acute bacterial infections (i.e., pneumonia), innate immunity, and inflammation. He completed his PhD degree in June 2009 from the Department of Microbiology, Panjab University, Chandigarh, India. Thereafter, he moved internationally and worked as a postdoctoral re-

searcher at various hospitals and universities in Canada, that is, Sainte-Justine Hospital, University de Montreal, Montreal, Quebec (2009–2010); Queens's University, Kingston, ON (2010–2012); and Sunnybrook Health Science Centre, University of Toronto, Toronto, ON (2012–2013). He worked with Translational Immunology Group at Trinity College, Dublin, Ireland (2014–2015). Currently, he is working with Children Health Clinical Unit, Faculty of Medicine at University of Queensland, Brisbane, Queensland, Australia. Dr. Kumar is the recipient of the prestigious "Piero Periti Review Article Award" for the year 2008, awarded by the *Journal of Chemotherapy* in the field of immunomodulation and antimicrobials for the article entitled "Innate Immunity in Sepsis Pathogenesis and Its Modulation: New Immunomodulatory Targets Revealed." He is the recipient of junior research and senior research fellowship [JRF and SRF (2004–2009)] offered by the Indian Council of Medical Research (ICMR), New Delhi, India. He has been awarded 13 travel awards to attend various international conferences in the field of sepsis and immunity. Till now, he has published 40 publications in peer-reviewed international journals in this field. He is also serving as an invited reviewer for many international journals.
